Sabra Health Care REIT, Inc. Plans Quarterly Dividend of $0.30 (NASDAQ:SBRA)

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced a quarterly dividend on Tuesday, February 4th,Wall Street Journal reports. Shareholders of record on Friday, February 14th will be given a dividend of 0.30 per share by the real estate investment trust on Friday, February 28th. This represents a $1.20 dividend on an annualized basis and a yield of 7.10%. The ex-dividend date of this dividend is Friday, February 14th.

Sabra Health Care REIT has raised its dividend payment by an average of 24.3% per year over the last three years. Sabra Health Care REIT has a payout ratio of 160.0% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect Sabra Health Care REIT to earn $1.45 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 82.8%.

Sabra Health Care REIT Stock Up 1.0 %

Shares of NASDAQ SBRA traded up $0.17 during midday trading on Wednesday, hitting $16.89. The stock had a trading volume of 64,959 shares, compared to its average volume of 1,616,075. The business’s 50 day moving average is $17.29 and its 200-day moving average is $17.63. Sabra Health Care REIT has a 52 week low of $12.85 and a 52 week high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. The company has a market cap of $4.00 billion, a P/E ratio of 41.22, a PEG ratio of 2.01 and a beta of 1.25.

Analyst Ratings Changes

A number of research firms have commented on SBRA. Truist Financial lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their target price for the stock from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Tuesday, January 7th. Finally, Scotiabank raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a report on Friday, October 11th. Three research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and an average price target of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.